Investors are on the edge of their collective seats, hoping that UnitedHealth Group
What analysts say:
- Buy, sell, or hold?: Analysts strongly back UnitedHealth Group, with 16 of 20 rating it a buy and the remainder rating it a hold. Analysts like UnitedHealth Group better than competitor WellPoint overall. Analysts still rate the stock a moderate buy, but they are a bit more wary about it compared to three months ago.
- Revenue forecasts: On average, analysts predict $25.45 billion in revenue this quarter. That would represent a rise of 7.5% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is earnings of $1.12 per share. Estimates range from $1.05 to $1.19.
What our community says:
CAPS All-Stars are solidly behind the stock with 98% giving it an "outperform" rating. The community at large concurs with the All-Stars with 95.6% awarding it a rating of "outperform." Fools are bullish on UnitedHealth Group and haven't been shy with their opinions lately, logging 1,042 posts in the past 30 days. UnitedHealth Group has a bullish CAPS rating of five out of five stars that is about on par with the Fool community assessment.
UnitedHealth Group's profit has risen year over year by an average of 14.9% over the past five quarters. Revenue has now gone up for three straight quarters.
We can help you keep tabs on your companies with My Watchlist, our free, personalized service. Add UnitedHealth Group now.
The Motley Fool owns shares of UnitedHealth Group. Motley Fool newsletter services have recommended buying shares of UnitedHealth Group. Motley Fool newsletter services have recommended creating a diagonal call position in UnitedHealth Group. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.